Boston Scientific
BSX
BSX
1,631 hedge funds and large institutions have $133B invested in Boston Scientific in 2025 Q1 according to their latest regulatory filings, with 233 funds opening new positions, 662 increasing their positions, 547 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more capital invested
Capital invested by funds: $120B → $133B (+$12.9B)
9% more funds holding
Funds holding: 1,500 → 1,631 (+131)
1.46% less ownership
Funds ownership: 90.69% → 89.24% (-1.5%)
Holders
1,631
Holding in Top 10
51
Calls
$1.07B
Puts
$819M
Top Buyers
| 1 | +$533M | |
| 2 | +$411M | |
| 3 | +$348M | |
| 4 |
D.E. Shaw & Co
New York
|
+$310M |
| 5 |
SP
SurgoCap Partners
New York
|
+$267M |
Top Sellers
| 1 | -$917M | |
| 2 | -$461M | |
| 3 | -$388M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$317M |
| 5 |
Impax Asset Management Group
London,
United Kingdom
|
-$304M |